Magal–D® Oral suspension

Each 10 ml contains:

Magaldrate 1080 mg + Simethicone 80 mg

INDICATIONS

Antiflatulent antacid indicated for the treatment of hyperacidity, bloating, duodenal ulcer, gastric ulcer, gastroesophageal reflux as well as in conditions of gastric hypersecretion such as Zollinger-Ellison syndrome, systemic mastocytosis and multiple endocrine adenomas.

PRESENTATIONS

Carton with bottle with 200 ml,  chocolate flavor

Classification ATC

A02AF01

Keywords: “Antiflatulent antacid indicated for the treatment of hyperacidity, bloating, duodenal ulcer, gastric ulcer, gastroesophageal reflux as well as in conditions of gastric hypersecretion such as Zollinger-Ellison syndrome, systemic mastocytosis and multiple endocrine adenomas”

Contacta a Dogma

Other products: